
Adial Pharmaceuticals Inc
NASDAQ:ADIL

Intrinsic Value
The intrinsic value of one
ADIL
stock under the Base Case scenario is
0.485
USD.
Compared to the current market price of 0.685 USD,
Adial Pharmaceuticals Inc
is
Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Adial Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Adial Pharmaceuticals Inc
Balance Sheet Decomposition
Adial Pharmaceuticals Inc
Current Assets | 2.6m |
Cash & Short-Term Investments | 2.4m |
Other Current Assets | 263.4k |
Non-Current Assets | 821.9k |
Long-Term Investments | 818.7k |
Intangibles | 3.2k |
Free Cash Flow Analysis
Adial Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Adial Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-8.7m
USD
|
Operating Income
|
-8.7m
USD
|
Other Expenses
|
-243k
USD
|
Net Income
|
-8.9m
USD
|
ADIL Profitability Score
Profitability Due Diligence
Adial Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Score
Adial Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
ADIL Solvency Score
Solvency Due Diligence
Adial Pharmaceuticals Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Score
Adial Pharmaceuticals Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ADIL Price Targets Summary
Adial Pharmaceuticals Inc
Dividends
Current shareholder yield for ADIL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ADIL
stock under the Base Case scenario is
0.485
USD.
Compared to the current market price of 0.685 USD,
Adial Pharmaceuticals Inc
is
Overvalued by 29%.